Historical Stock Price
ETFs Holding ACRS »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
11/24/2021 $12.75 $13.47 $12.58 $13.40 245.30K
11/26/2021 $12.87 $13.24 $12.40 $12.62 216.20K
11/29/2021 $12.92 $13.03 $12.14 $12.27 254.20K
11/30/2021 $12.65 $13.00 $12.01 $12.80 840.00K
12/01/2021 $13.06 $13.52 $12.49 $12.51 601.50K
Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on developing drug candidates for immuno-inflammatory diseases. Co.'s pipeline of drug candidates that Co. is developing includes: ATI-450, an investigational oral, small molecule selective MK2 inhibitor compound for the treatment of rheumatoid arthritis; and ATI-1777, an investigational topical soft JAK 1/3 inhibitor compound, for the treatment of moderate to severe atopic dermatitis. Co. is also developing ATI-2138, an investigational oral ITK/TXK/JAK3 inhibitor compound, as a potential treatment for psoriasis and/or inflammatory bowel disease, which are both T-cell mediated autoimmune diseases.
ACRS historical stock prices picture
Aclaris Therapeutics (ACRS) has the following price history information. Looking back at ACRS historical stock prices for the last five trading days, on November 24, 2021, ACRS opened at $12.75, traded as high as $13.47 and as low as $12.58, and closed at $13.40. Trading volume was a total of 245.30K shares. On November 26, 2021, ACRS opened at $12.87, traded as high as $13.24 and as low as $12.40, and closed at $12.62. Trading volume was a total of 216.20K shares. On November 29, 2021, ACRS opened at $12.92, traded as high as $13.03 and as low as $12.14, and closed at $12.27. Trading volume was a total of 254.20K shares. On November 30, 2021, ACRS opened at $12.65, traded as high as $13.00 and as low as $12.01, and closed at $12.80. Trading volume was a total of 840.00K shares. On December 01, 2021, ACRS opened at $13.06, traded as high as $13.52 and as low as $12.49, and closed at $12.51. Trading volume was a total of 601.50K shares.

ACRS Historical Stock Prices By Date:

ACRS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aclaris Therapeutics shares, starting with a $10,000 purchase of ACRS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/07/2015
End date: 12/01/2021
Start price/share: $11.05
End price/share: $12.51
Dividends collected/share: $0.00
Total return: 13.21%
Average Annual Total Return: 2.04%
Starting investment: $10,000.00
Ending investment: $11,323.80
Years: 6.16
Date Close
11/24/2021$13.40
11/26/2021$12.62
11/29/2021$12.27
11/30/2021$12.80
12/01/2021$12.51
ACRS is categorized under the Healthcare sector; below are some other companies in the same sector:

ACRX Historical Stock Prices
ACST Historical Stock Prices
ACT Historical Stock Prices
ACUR Historical Stock Prices
ADHD Historical Stock Prices
ADK Historical Stock Prices
ADMA Historical Stock Prices
ADMP Historical Stock Prices
ADMS Historical Stock Prices
ADPT Historical Stock Prices

Also explore: ACRS shares outstanding history

Email EnvelopeFree ACRS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

ACRS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.